Facilitated By

San Antonio Medical Foundation

TARGETING CANCER STEM CELLS USING NOVEL LYSINE-SPECIFIC DEMTHYLASE 1A INHIBITOR FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Sareddy,Gangadhara Reddy
Funded by
UNIVERSITY OF TEXAS FOUNDATION
Research Start Date
Status
Active
Clinical Care
Cancer